Although current Alzheimer’s treatments cannot stop Alzheimer’s from progressing, they can temporarily slow the worsening of dementia symptoms and improve quality of life for those with Alzheimer’s and their caregivers.
Meridien Research is seeking volunteers for participation in a test of an investigational Alzheimer’s Disease medication. If you are 50 to 85 years of age and have been diagnosed with Mild Cognitive Impairment (MCI), you may be eligible to participate.
Qualified participants will receive at no cost study-related evaluations. Compensation for time and travel may be available to participants and their caregivers. No medical insurance is necessary. Contact Meridien Research today to get more information at 352-597-8839.